|
81 |
Outcome and prognostic factors of desmoplastic medulloblastoma treated within a multidisciplinary treatment concept
Enthalten in BMC cancer Bd. 10, 23.8.2010, Nr. 1, date:12.2010: 1-10
|
|
|
|
82 |
Perioperative imaging in patients treated with resection of brain metastases: a survey by the European Association of Neuro-Oncology (EANO) Youngsters committee
Enthalten in BMC cancer Bd. 20, 12.5.2020, Nr. 1, date:12.2020: 1-10
|
|
|
|
83 |
Plasmatic MMP9 released from tumor-infiltrating neutrophils is predictive for bevacizumab efficacy in glioblastoma patients: an AVAglio ancillary study
Enthalten in Acta Neuropathologica Communications Bd. 10, 3.1.2022, Nr. 1, date:12.2022: 1-14
|
|
|
|
84 |
Pleomorphic xanthoastrocytoma is a heterogeneous entity with pTERT mutations prognosticating shorter survival
Enthalten in Acta Neuropathologica Communications Bd. 10, 10.1.2022, Nr. 1, date:12.2022: 1-10
|
|
|
|
85 |
Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience
Enthalten in Acta neuropathologica Bd. 136, 2.7.2018, Nr. 2, date:8.2018: 181-210
|
|
|
|
86 |
Prognostic significance of IDH-1 and MGMT in patients with glioblastoma: One step forward, and one step back?
Enthalten in Radiation oncology Bd. 6, 13.9.2011, Nr. 1, date:12.2011: 1-5
|
|
|
|
87 |
Prospective, multicenter validation of a platform for rapid molecular profiling of central nervous system tumors
Enthalten in Nature medicine Bd. 31, 25.3.2025, Nr. 5, date:5.2025: 1567-1577
|
|
|
|
88 |
Randomised phase I/II study to evaluate carbon ion radiotherapy versus fractionated stereotactic radiotherapy in patients with recurrent or progressive gliomas: The CINDERELLA trial
Enthalten in BMC cancer Bd. 10, 6.10.2010, Nr. 1, date:12.2010: 1-8
|
|
|
|
89 |
Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: The CLEOPATRA Trial
Enthalten in BMC cancer Bd. 10, 6.9.2010, Nr. 1, date:12.2010: 1-9
|
|
|
|
90 |
Rapid-CNS2: rapid comprehensive adaptive nanopore-sequencing of CNS tumors, a proof-of-concept study
Enthalten in Acta neuropathologica Bd. 143, 31.3.2022, Nr. 5, date:5.2022: 609-612
|
|
Administration
